全文获取类型
收费全文 | 85965篇 |
免费 | 7423篇 |
国内免费 | 4416篇 |
专业分类
耳鼻咽喉 | 621篇 |
儿科学 | 2446篇 |
妇产科学 | 481篇 |
基础医学 | 5356篇 |
口腔科学 | 404篇 |
临床医学 | 6693篇 |
内科学 | 21507篇 |
皮肤病学 | 1178篇 |
神经病学 | 3196篇 |
特种医学 | 3498篇 |
外国民族医学 | 16篇 |
外科学 | 10715篇 |
综合类 | 12772篇 |
现状与发展 | 20篇 |
一般理论 | 3篇 |
预防医学 | 3594篇 |
眼科学 | 698篇 |
药学 | 14564篇 |
36篇 | |
中国医学 | 5743篇 |
肿瘤学 | 4263篇 |
出版年
2024年 | 168篇 |
2023年 | 1448篇 |
2022年 | 2067篇 |
2021年 | 3311篇 |
2020年 | 3114篇 |
2019年 | 3112篇 |
2018年 | 3126篇 |
2017年 | 3309篇 |
2016年 | 3477篇 |
2015年 | 3165篇 |
2014年 | 5288篇 |
2013年 | 6092篇 |
2012年 | 4563篇 |
2011年 | 5032篇 |
2010年 | 3959篇 |
2009年 | 3706篇 |
2008年 | 3758篇 |
2007年 | 3800篇 |
2006年 | 3526篇 |
2005年 | 3004篇 |
2004年 | 2430篇 |
2003年 | 2355篇 |
2002年 | 2843篇 |
2001年 | 3077篇 |
2000年 | 3015篇 |
1999年 | 2142篇 |
1998年 | 2064篇 |
1997年 | 1823篇 |
1996年 | 1332篇 |
1995年 | 918篇 |
1994年 | 742篇 |
1993年 | 639篇 |
1992年 | 605篇 |
1991年 | 495篇 |
1990年 | 447篇 |
1989年 | 377篇 |
1988年 | 351篇 |
1987年 | 274篇 |
1986年 | 264篇 |
1985年 | 352篇 |
1984年 | 312篇 |
1983年 | 225篇 |
1982年 | 254篇 |
1981年 | 219篇 |
1980年 | 201篇 |
1979年 | 185篇 |
1978年 | 176篇 |
1977年 | 157篇 |
1976年 | 156篇 |
1975年 | 87篇 |
排序方式: 共有10000条查询结果,搜索用时 426 毫秒
21.
22.
23.
Guo-Chao Zhong Yang Peng Kang Wang Lun Wan You-Qi-Le Wu Fa-Bao Hao Jie-Jun Hu Hai-Tao Gu 《International journal of cancer. Journal international du cancer》2020,147(6):1577-1586
Epidemiological studies on magnesium intake and primary liver cancer (PLC) are scarce, and no prospective studies have examined the associations of magnesium intake with PLC incidence and mortality. We sought to clarify whether higher magnesium intake from diet and supplements was associated with lower risks of PLC incidence and mortality in the US population. Magnesium intake from diet and supplements was evaluated through a food frequency questionnaire in a cohort of 104,025 participants. Cox regression was employed to calculate hazard ratios for PLC incidence and competing risk regression was employed to calculate subdistribution hazard ratios for PLC mortality. Restricted cubic spline regression was employed to test nonlinearity. We documented 116 PLC cases during 1,193,513.5 person-years of follow-up and 100 PLC deaths during 1,198,021.3 person-years of follow-up. Total (diet + supplements) magnesium intake was found to be inversely associated with risks of PLC incidence (hazard ratiotertile 3 vs. 1: 0.44; 95% confidence interval: 0.24, 0.80; ptrend = 0.0065) and mortality (subdistribution hazard ratiotertile 3 vs. 1: 0.37; 95% confidence interval: 0.19, 0.71; ptrend = 0.0008). Similar results were obtained for dietary magnesium intake. Nonlinear inverse dose–response associations with PLC incidence and mortality were observed for both total and dietary magnesium intakes (all pnonlinearity < 0.05). In summary, in the US population, a high magnesium intake is associated with decreased risks of PLC incidence and mortality in a nonlinear dose–response manner. These findings support that increasing the consumption of foods rich in magnesium may be beneficial in reducing PLC incidence and mortality. 相似文献
24.
新型冠状病毒肺炎(新冠肺炎)对人民的生命健康造成了巨大的威胁。在新冠肺炎疫情下,如何应对肝胆外科肝癌患者的门诊筛查、病房管理以及安全地实施肝癌手术,都是对肝胆外科医师提出的新挑战。我们认为,该病的临床处置应在筛查新冠肺炎的前提下,遵循正规操作流程,做好充分防护。对于需要急诊治疗但无法排除新冠肺炎的肝癌患者,须综合考虑患者的病情严重程度、手术方式及手术室条件,慎重制定个体化治疗方案。整个诊疗过程必须遵从既保证患者的安全及疗效,又要降低医护人员感染风险的原则。 相似文献
25.
Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver‐related morbidity; its prevalence is elevating due to the rising epidemic of obesity. Several clinical trials have examined the effects of curcumin supplementation on anthropometric variables in NAFLD patients with inconclusive results. This dose–response meta‐analysis aimed to evaluate the impact of curcumin supplementation on body mass index (BMI), body weight, and waist circumference (WC) in patients with NAFLD. A systematic review of the literature was conducted using PubMed/Medline, ISI Web of Science, Scopus, Cochrane Library, EMBASE, Google Scholar, Sid.ir, and Magiran.com to identify eligible studies up to March 2019. A meta‐analysis of eligible studies was performed using the random‐effects model to estimate the pooled effect size. Eight randomized controlled trials with 520 participants (curcumin group = 265 and placebo group = 255) were included. Supplementation dose and duration ranged from 70 to 3,000 mg/day and 8 to 12 weeks, respectively. Curcumin supplementation significantly reduced BMI (weighted mean difference [WMD] = ?0.34 kg/m2, 95% CI [?0.64, ?0.04], p < .05) and WC (WMD = ?2.12 cm, 95% CI [?3.26, ?0.98], p < .001). However, no significant effects of curcumin supplementation on body weight were found. These results suggest that curcumin supplementation might have a positive effect on visceral fat and abdominal obesity that have been associated with NAFLD. 相似文献
26.
Daisuke Ishibashi Takeshi Ishikawa Satoshi Mizuta Hiroya Tange Takehiro Nakagaki Tsuyoshi Hamada Noriyuki Nishida 《Neurotherapeutics》2020,17(4):1836
The accumulation of abnormal prion protein (PrPSc) produced by the structure conversion of PrP (PrPC) in the brain induces prion disease. Although the conversion process of the protein is still not fully elucidated, it has been known that the intramolecular chemical bridging in the most fragile pocket of PrP, known as the “hot spot,” stabilizes the structure of PrPC and inhibits the conversion process. Using our original structure-based drug discovery algorithm, we identified the low molecular weight compounds that predicted binding to the hot spot. NPR-130 and NPR-162 strongly bound to recombinant PrP in vitro, and fragment molecular orbital (FMO) analysis indicated that the high affinity of those candidates to the PrP is largely dependent on nonpolar interactions, such as van der Waals interactions. Those NPRs showed not only significant reduction of the PrPSc levels but also remarkable decrease of the number of aggresomes in persistently prion-infected cells. Intriguingly, treatment with those candidate compounds significantly prolonged the survival period of prion-infected mice and suppressed prion disease-specific pathological damage, such as vacuole degeneration, PrPSc accumulation, microgliosis, and astrogliosis in the brain, suggesting their possible clinical use. Our results indicate that in silico drug discovery using NUDE/DEGIMA may be widely useful to identify candidate compounds that effectively stabilize the protein.Electronic supplementary materialThe online version of this article (10.1007/s13311-020-00903-9) contains supplementary material, which is available to authorized users. 相似文献
27.
目的 探讨肝动脉化疗栓塞(transcatheter arterial chemoembolization,TACE)术前天冬氨酸氨基转移酶与淋巴细胞比值(aspartate aminotransferase to lymphocyte ratio index,ALRI)在原发性肝癌并门脉癌栓(primary liver cancer-portal vein tumor thrombosis,PLC-PVTT)患者预后预测中的价值。方法 选取2013年11月21日至2018年8月22日于广西医科大学附属肿瘤医院接受TACE治疗的175例PLC-PVTT患者为研究对象。采用时间依赖性ROC曲线确定ALRI的最佳临界值。采用Cox 回归模型分析总生存期(overall survival,OS)的独立预测因素,Kaplan-Meier法计算生存率。结果 ROC曲线显示,ALRI的最佳临界值为49.37,对应曲线下面积为0.71。Kaplan-Meier分析显示,ALRI>49.37的患者OS较ALRI≤49.37的患者短(P=0.003)。Cox 回归分析结果显示,ALRI>49.37、行1次以上TACE治疗、Child-Pugh分级B级、凝血酶原时间≥13 s是患者TACE术后OS的独立危险因素(均P<0.05)。结论 TACE术前ALRI>49.37是PLC-PVTT患者OS的独立危险因素。 相似文献
28.
29.
30.
Sebastian P. Mondaca MD Dazhi Liu PharmD BCOP Jessica R. Flynn Sandy Badson Stefan Hamaway BS Mrinal M. Gounder MD Danny N. Khalil MD PhD Alexander E. Drilon MD Bob T. Li MD MPH Komal L. Jhaveri MD Alison M. Schram MD Katherine E. Kargus RN Mary Kate Kasler DNP MSN Natalie M. Blauvelt Neil H. Segal MD PhD Marinela Capanu PhD Margaret K. Callahan MD PhD David M. Hyman MD Maya Gambarin-Gelwan MD James J. Harding MD 《Cancer》2020,126(22):4967-4974